Veterinary Medicines

CLAVASEPTIN P 50 MG TABLETS FOR DOGS AND CATS

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate
Download as PDF

Product identification

Medicine name:
CLAVASEPTIN P 50 MG TABLETS FOR DOGS AND CATS
CLAVASEPTIN 50 mg Tabletten für Hunde und Katzen
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    45.91
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    11.91
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:
  • Cardboard box of 1 blister of 10 tablets
  • Cardboard box of 100 blisters of 10 tablets
  • Cardboard box of 75 blisters of 10 tablets
  • Cardboard box of 60 blisters of 10 tablets
  • Cardboard box of 50 blisters of 10 tablets
  • Cardboard box of 40 blisters of 10 tablets
  • Cardboard box of 30 blisters of 10 tablets
  • Cardboard box of 25 blisters of 10 tablets
  • Cardboard box of 20 blisters of 10 tablets
  • Cardboard box of 15 blisters of 10 tablets
  • Cardboard box of 12 blisters of 10 tablets
  • Cardboard box of 10 blisters of 10 tablets
  • Cardboard box of 5 blisters of 10 tablets
  • Cardboard box of 2 blisters of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol Oesterreich GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00654
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0407/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 19/03/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 19/03/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 19/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."